Journal of Neuro-Oncology

, Volume 107, Issue 1, pp 139–146 | Cite as

Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database

  • Birte Wolff
  • Ann Ng
  • Daniela Roth
  • Kathleen Parthey
  • Monika Warmuth-Metz
  • Matthias Eyrich
  • Uwe Kordes
  • Rolf Kortmann
  • Torsten Pietsch
  • Christof Kramm
  • Johannes EA Wolff
Clinical Study – Patient Study

Abstract

Little is known about pediatric spinal cord high grade gliomas (SCHGG) beyond their dismal prognosis. Here, we analyzed the HIT-GBM® database for the influence of surgical resection on survival. Between 1991 and 2010 the HIT-GBM group collected data from European children diagnosed with high grade glioma. Patients with the following inclusion criteria were analyzed in this study: astrocytic histology, WHO grade III or IV, age at diagnosis <18 years, and tumor localized to the spinal cord. 28 patients (mean age 11.28 years, 14 male) with primary SCHGG were identified. The tumor sizes were measured by the span across adjacent vertebrae and varied greatly (range: 1–20, median: 4). Histology was classified as WHO grade III in 15 and grade IV in 13 tumors. Of note, the four largest tumors identified were WHO grade III. Surgery was classified as complete resection (n = 6), subtotal resection (STR) (n = 7), partial resection (n = 12) or biopsy only (n = 3). 27 patients received chemotherapy, 22 of which also received radiation. With the mean follow-up time of 2.88 (SD ± 2.95) years, 14 patients were still alive resulting in a median overall survival of 2.5 years (SE ± 1.6). The positive prognostic indicators for overall survival were: age younger than 5 years (P = 0.047), WHO grade III (P = 0.046), absence of necrosis (P = 0.025) and gross total resection (GTR) (P = 0.012). The prognosis of SCHGG might not be as miserable as generally assumed. GTR is of benefit. Larger data sets and meta-analysis are necessary to identify patient sub-groups.

Keywords

Pediatric high grade glioma GBM Spinal cord Gross total resection HIT-GBM database 

References

  1. 1.
    Bouffet E, Pierre-Kahn A, Marchal JC, Jouvet A, Kalifa C, Choux M, Dhellemmes P, Guerin J, Tremoulet M, Mottolese C (1998) Prognostic factors in pediatric spinal cord astrocytoma. Cancer 83(11):2391–2399. doi:10.1002/(SICI)1097-0142(19981201)83:11<2391:AID-CNCR20>3.0.CO;2-0 PubMedCrossRefGoogle Scholar
  2. 2.
    Cristante L, Herrmann HD (1994) Surgical management of intramedullary spinal cord tumors: functional outcome and sources of morbidity. Neurosurgery 35(1):69–74 discussion 74–66PubMedCrossRefGoogle Scholar
  3. 3.
    Epstein FJ, Farmer JP (1990) Pediatric spinal cord tumor surgery. Neurosurg Clin N Am 1(3):569–590PubMedGoogle Scholar
  4. 4.
    Allen JC, Aviner S, Yates AJ, Boyett JM, Cherlow JM, Turski PA, Epstein F, Finlay JL (1998) Treatment of high-grade spinal cord astrocytoma of childhood with “8-in-1” chemotherapy and radiotherapy: a pilot study of CCG-945. Children’s Cancer Group. J Neurosurg 88(2):215–220. doi:10.3171/jns.1998.88.2.0215 PubMedCrossRefGoogle Scholar
  5. 5.
    Wolff JE, Classen CF, Wagner S, Kortmann RD, Palla SL, Pietsch T, Kuhl J, Gnekow A, Kramm CM (2008) Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. J Neurooncol 87(2):155–164. doi:10.1007/s11060-007-9495-z PubMedCrossRefGoogle Scholar
  6. 6.
    Kramm CM, Wagner S, Van Gool S, Schmid H, Strater R, Gnekow A, Rutkowski S, Wolff JE (2006) Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 26(5B):3773–3779PubMedGoogle Scholar
  7. 7.
    Constantini S, Houten J, Miller DC, Freed D, Ozek MM, Rorke LB, Allen JC, Epstein FJ (1996) Intramedullary spinal cord tumors in children under the age of 3 years. J Neurosurg 85(6):1036–1043. doi:10.3171/jns.1996.85.6.1036 PubMedCrossRefGoogle Scholar
  8. 8.
    McGirt MJ, Chaichana KL, Atiba A, Attenello F, Woodworth GF, Jallo GI (2008) Neurological outcome after resection of intramedullary spinal cord tumors in children. Childs Nerv Syst 24(1):93–97. doi:10.1007/s00381-007-0446-y PubMedCrossRefGoogle Scholar
  9. 9.
    Reimer R, Onofrio BM (1985) Astrocytomas of the spinal cord in children and adolescents. J Neurosurg 63(5):669–675. doi:10.3171/jns.1985.63.5.0669 PubMedCrossRefGoogle Scholar
  10. 10.
    McGirt MJ, Goldstein IM, Chaichana KL, Tobias ME, Kothbauer KF, Jallo GI (2008) Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. Neurosurgery 63(1):55–60. doi:10.1227/01.NEU.0000335070.37943.09 discussion 60–51PubMedCrossRefGoogle Scholar
  11. 11.
    Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ (2000) Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg 93(2):183–193PubMedGoogle Scholar
  12. 12.
    Wolff JE, Driever PH, Erdlenbruch B, Kortmann RD, Rutkowski S, Pietsch T, Parker C, Metz MW, Gnekow A, Kramm CM (2010) Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer 116(3):705–712. doi:10.1002/cncr.24730 PubMedCrossRefGoogle Scholar
  13. 13.
    Karremann M, Pietsch T, Janssen G, Kramm CM, Wolff JE (2009) Anaplastic ganglioglioma in children. J Neurooncol 92(2):157–163. doi:10.1007/s11060-008-9747-6 PubMedCrossRefGoogle Scholar
  14. 14.
    Benesch M, Wagner S, Berthold F, Wolff JE (2005) Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH). J Neurooncol 72(2):179–183. doi:10.1007/s11060-004-3546-5 PubMedCrossRefGoogle Scholar
  15. 15.
    Classen CF, Warmuth-Metz M, Papke K, Trotter A, Wolff JE, Wagner S (2006) Late response to radiochemotherapy in pediatric glioblastoma: report on two patients treated according to HIT-GBM protocols. Pediatr Hematol Oncol 23(8):631–637. doi:10.1080/08880010600951088 PubMedCrossRefGoogle Scholar
  16. 16.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109PubMedCrossRefGoogle Scholar
  17. 17.
    Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352(10):978–986. doi:10.1056/NEJMoa042176 PubMedCrossRefGoogle Scholar
  18. 18.
    Wolff JE, Kortmann RD, Wolff B, Pietsch T, Peters O, Schmid HJ, Rutkowski S, Warmuth-Metz M, Kramm C (2011) High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot study. J Neurooncol 102(3):433–442. doi:10.1007/s11060-010-0334-2 PubMedCrossRefGoogle Scholar
  19. 19.
    Wagner S, Warmuth-Metz M, Emser A, Gnekow AK, Strater R, Rutkowski S, Jorch N, Schmid HJ, Berthold F, Graf N, Kortmann RD, Pietsch T, Sorensen N, Peters O, Wolff JE (2006) Treatment options in childhood pontine gliomas. J Neurooncol 79(3):281–287. doi:10.1007/s11060-006-9133-1 PubMedCrossRefGoogle Scholar
  20. 20.
    Packer RJ (1994) Diagnosis and treatment of pediatric brain tumors. Curr Opin Neurol 7(6):484–491PubMedCrossRefGoogle Scholar
  21. 21.
    Cohen AR, Wisoff JH, Allen JC, Epstein F (1989) Malignant astrocytomas of the spinal cord. J Neurosurg 70(1):50–54. doi:10.3171/jns.1989.70.1.0050 PubMedCrossRefGoogle Scholar
  22. 22.
    Rossitch E Jr, Zeidman SM, Burger PC, Curnes JT, Harsh C, Anscher M, Oakes WJ (1990) Clinical and pathological analysis of spinal cord astrocytomas in children. Neurosurgery 27(2):193–196PubMedCrossRefGoogle Scholar
  23. 23.
    Guidetti B, Mercuri S, Vagnozzi R (1981) Long-term results of the surgical treatment of 129 intramedullary spinal gliomas. J Neurosurg 54(3):323–330. doi:10.3171/jns.1981.54.3.0323 PubMedCrossRefGoogle Scholar
  24. 24.
    Hargrave DR, Zacharoulis S (2007) Pediatric CNS tumors: current treatment and future directions. Expert Rev Neurother 7(8):1029–1042. doi:10.1586/14737175.7.8.1029 PubMedCrossRefGoogle Scholar
  25. 25.
    Crawford JR, Zaninovic A, Santi M, Rushing EJ, Olsen CH, Keating RF, Vezina G, Kadom N, Packer RJ (2009) Primary spinal cord tumors of childhood: effects of clinical presentation, radiographic features, and pathology on survival. J Neurooncol 95(2):259–269. doi:10.1007/s11060-009-9925-1 PubMedCrossRefGoogle Scholar
  26. 26.
    Houten JK, Weiner HL (2000) Pediatric intramedullary spinal cord tumors: special considerations. J Neurooncol 47(3):225–230PubMedCrossRefGoogle Scholar
  27. 27.
    Wolff JE, Mohiuddin K, Jorch N, Graf N, Wagner S, Vats T, Gnekow A (2010) Measuring performance status in pediatric patients with brain tumors–experience of the HIT-GBM-C protocol. Pediatr Blood Cancer 55(3):520–524. doi:10.1002/pbc.22566 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2011

Authors and Affiliations

  • Birte Wolff
    • 1
  • Ann Ng
    • 1
  • Daniela Roth
    • 2
  • Kathleen Parthey
    • 2
  • Monika Warmuth-Metz
    • 3
  • Matthias Eyrich
    • 4
  • Uwe Kordes
    • 5
  • Rolf Kortmann
    • 6
  • Torsten Pietsch
    • 7
  • Christof Kramm
    • 8
  • Johannes EA Wolff
    • 9
  1. 1.Baylor College of Medicine, BCM368HoustonUSA
  2. 2.University of Halle, HIT-HGG-StudienzentraleHalleGermany
  3. 3.NeuroradiologyUniversity of WürzburgWürzburgGermany
  4. 4.Department of Stem Cell TransplantationUniversity Children’s Hospital of WürzburgWürzburgGermany
  5. 5.University of HamburgHamburgGermany
  6. 6.Department of Radiation OncologyUniversity of LeipzigLeipzigGermany
  7. 7.NeuropathologyUniversity of BonnBonnGermany
  8. 8.University Children’s HospitalUniversity of HalleHalleGermany
  9. 9.Department of PediatricsTufts Medical CenterBostonUSA

Personalised recommendations